Who We Are




  • When it comes to the heart of our company, these words describe us best: “Passion for Innovation. Compassion for Patients.” We are dedicated to helping people around the world live healthy and meaningful lives. In order to find new ways to enhance medicines, our employees work relentlessly and passionately day by day. It is because everybody is committed to implementing their ideas and individual strengths that we achieve the extraordinary.

  • With about 15,000 employees, we are one of the biggest pharmaceutical companies in the world. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology.

  • Our European Headquarters is based in Munich, Germany. Here we coordinate the business activities within Europe, comprising about 1,500 employees in different affiliates, including Germany, Austria, Switzerland, UK, Ireland, the Netherlands, Belgium, France, Italy, Spain, Portugal, Denmark and Turkey. In the north of Munich, in Pfaffenhofen, one of our production plants is located. Equipped with state-of-the-art technology, our employees produce pharmaceuticals for more than 50 countries in the world. Thereby, they strictly follow GMP (Good Manufacturing Practices) regulations.